MedTrace Logo

Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic

NCT05556772 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 619

Last updated 2025-12-16

No results posted yet for this study

Summary

This study compares different screening approaches to detect abnormal cell growth on the cervix that could be an early sign of cervical cancer. The lesions are caused by an infection of human papillomavirus, also called HPV. Using new methods to detect HPV may help doctors find ways to improve cervical cancer screening for women living with human immunodeficiency virus (HIV) in the Dominican Republic and in other countries.

Conditions

  • Malignant Female Reproductive System Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Collection of blood; urine; cervical, anal, vaginal samples

OTHER

Interview

Attend interview

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)

    collaborator UNKNOWN

  • Instituto Dermatológico Dominicano y Cirugía de Piel (IDCP)

    collaborator UNKNOWN

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Margaret M. Madeleine, PhD, MPH · Fred Hutchinson Cancer Center

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2025-10-31
Completion
2026-07-31

Countries

  • Dominican Republic

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05556772 on ClinicalTrials.gov